Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F22%3A43920874" target="_blank" >RIV/00023752:_____/22:43920874 - isvavai.cz</a>
Alternative codes found
RIV/67985823:_____/22:00558392 RIV/00064173:_____/22:43923520 RIV/00216208:11120/22:43923520
Result on the web
<a href="https://www.frontiersin.org/articles/10.3389/fneur.2022.874121/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fneur.2022.874121/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fneur.2022.874121" target="_blank" >10.3389/fneur.2022.874121</a>

Result language
angličtina
Original language name
Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study
Original language description
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) leading to the loss of myelin and axons. Diagnosis is based on clinical findings, MRI, and analysis of cerebrospinal fluid (CSF). CSF is an ultrafiltrate of plasma and reflects inflammatory processes in the CNS. The aim of this study was to perform metabolomics analysis of CSF in patients after the first attack of MS and healthy controls and try to find new specific analytes for MS including those potentially predicting disease activities at the onset.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30103 - Neurosciences (including psychophysiology)

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)